NOS2 and type 2 diabetes mellitus: Since ROZ, although debated, has been suggested to be an alternative drug in long-term therapy of type 2 diabetes we were particularly interested in the action of ROZ on long-term effects of FFA, as represented by palmitate, on islet activation of ncNOS and iNOS in relation to glucose-stimulated insulin release.